February 25 - 26, 2013    Las Vegas NV , USA
We welcome you to GTC's 2nd Novel Cancer Therapeutics Summit taking place on February 25-26, 2013 in Las Vegas, NV. This summit brings together experts from academia and industry to discuss the emerging targets, therapeutics and strategies against cancer, as well as showcase ubiquitins' huge potential in the development of therapeutics. Attendees will also receive updates on government policy, recent regulations, important investments and partnering strategies.

2nd Novel Cancer Therapeutics Summit consists of three concurrent conferences shown below:
• 4th Cancer Targets & Therapeutics
• 2nd Oncology Partnering & Deal-making
• 3rd Ubiquitin Research & Drug Discovery

• Keynote Speaker
Aaron Ciechanover

Dedicated networking events have been incorporated to enhance the exchange of information between technology developers and end-users. The 2nd Novel Cancer Therapeutics Summit will provide a great opportunity for companies to expose products and services

Call for Papers!
To be considered for an oral presentation, please submit an abstract here by January 25, 2013. Selected presentations will be based on quality of abstract and availability. Presentation slots fill up fast so please submit your abstract ASAP.
Summit registration gives you access to all Three tracks!
Sponsorship and exhibiting opportunities are available in a range of levels, which can be tailored to fit your needs. Please contact 626-256-6405 x102 or gtcsales@gtcbio.com for more information

Venue

Location: Palms Casino Resort
Contact 4321 W Flamingo Rd. Las Vegas , USA

Organizer

Global Technology Community
434 W. Foothill Blvd | Monrovia, CA 91016
626-256-6405

Related events

Novel Cancer Therapeutics Summit October 19 - 20, 2017
Novel Cancer Therapeutics Summit November 7 - 9, 2016
Novel Cancer Therapeutics Summit February 25 - 26, 2013